Diabetes Type 2 clinical trials at UC Irvine

1 research study open to eligible people

Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
open to eligible people ages 18-99
The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.
Orange, California and other locations

Last updated: July 24, 2025